Addtech Life Science
Addtech Life Science's net sales were SEK 1,393 million (1,141), a 22 percent increase. Operating profit rose by 16 percent to SEK 125 million (108).
The business area enjoyed good growth in earnings over the financial year, despite a relative weaker result in the fourth quarter. Overall, demand for this business area continued to grow during the final quarter. Demand for diagnostic equipment and reagents for the Nordic healthcare sector was good throughout the financial year. Conditions improved during the year for measuring and analysis instruments for the Nordic process industry, particularly in the marine segment. Demand for equipment and reagents for healthcare and research laboratories over the year was stable.
During the year this business area made one acquisition, Vimex AS.
Grafbild |
Grafbild |
| Addtech Life Science | ||
|---|---|---|
| 2013/2014 | 2012/2013 | |
| Net sales, SEKm | 1,393 | 1,141 |
| Operating profit, SEKm | 125 | 108 |
| Operating margin, % | 9.0 | 9.5 |
| Working capital year average, SEKm | 201 | 147 |
| Return on working capital (P/WC), % | 62 | 74 |
| Average number of employees | 436 | 347 |